Alternatives to DoubleJump Interchange

At Komodo Health, we integrate an extensive understanding of patient interactions with cutting-edge algorithms and years of clinical knowledge to create our Healthcare Map, which offers the most accurate representation of the U.S. healthcare landscape. This Healthcare Map serves as the backbone for our comprehensive suite of software solutions, designed to help you provide exceptional value to your customers, colleagues, and patients alike. Relying solely on traditional scholarly data for strategic planning is now outdated. Our Aperture platform has been meticulously crafted to deliver unparalleled insights into clinical leadership and influence, enabling improvements in care standards where they are needed most—whether that involves the most referenced author, a prominent social media influencer, or the physician with the highest patient volume. Moreover, conventional open/sampled prescription and patient-level data often overlook critical patterns that are essential for accurately identifying individuals with complex care needs or uncommon medical conditions. By addressing these gaps, we aim to enhance patient outcomes and streamline healthcare delivery.

Atropos Health delivers immediate access to real-world data evidence, bridging the gaps in healthcare and life sciences. Demonstrated to enhance clinical outcomes, hasten research efforts, and improve operational efficiency, Atropos Health swiftly converts medical information into actionable real-world evidence, reducing research timelines from months to mere minutes. Central to our offerings is a generative evidence acceleration operating system that enables the secure installation and structuring of medical data for future applications. Our sophisticated analytics tools allow for the generation of evidence on demand and can seamlessly integrate with your existing data systems post-installation, or utilize our extensive global evidence network comprising over 160 million patient records and a library of 10,000 previous studies right away. By collaborating with Atropos Health, leading health systems and life science organizations can expedite research, refine clinical trials, enhance clinical decision-making, address variations in care, and more, ultimately transforming the landscape of healthcare innovation. Join us in revolutionizing the way evidence is harnessed in medicine.

H1 Universe is an innovative platform that leverages artificial intelligence to enhance the management of healthcare data, offering users access to the most extensive global database of healthcare providers (HCPs). By merging information from various sources, such as public, private, and proprietary databases, H1 Universe provides valuable insights that are crucial for clinical trials, medical affairs, and commercialization efforts. This powerful tool enables healthcare teams to pinpoint essential stakeholders, refine clinical research processes, and make informed decisions swiftly, ultimately boosting overall efficiency within the healthcare landscape. Furthermore, the platform not only aids in real-time decision-making but also fosters collaboration among healthcare professionals, paving the way for improved patient outcomes.

Grounded in established medical science and transparent systems biology, DARA enhances clinical decision-making and intervention strategies. Collaborating with healthcare providers and relevant stakeholders, we deliver digital solutions that revolutionize health screening and the management of chronic diseases. Our approach facilitates the digital evolution of care delivery through the automation of clinical workflows and the use of predictive analytics, all aligned with leading clinical guidelines and best practices. By offering actionable health insights through tailored predictions of disease risk and potential adverse events, we empower physicians to better connect with their patients. Additionally, we support pharmaceutical development by uncovering pharmacodynamics within intricate biological systems and discovering innovative therapeutic options. Utilizing predictive analytics on comprehensive patient data allows for personalized precision medicine, particularly in managing cardiometabolic diseases to avert severe patient outcomes. With our tools, healthcare can become more proactive and responsive, ultimately leading to improved patient care and health outcomes.

We assess health beyond traditional healthcare environments to gain a deeper insight into the burden of diseases. This holistic perspective on patient wellness reveals new business avenues by introducing innovative metrics for understanding disease and patient health. By cultivating a patient-focused comprehension of how diseases affect daily functioning, we can engage both physicians and payers more effectively while enhancing patient support initiatives. Furthermore, we aim to develop sophisticated algorithms that can forecast disease onset and its progression or regression, as well as pinpoint critical moments for intervention. Utilize actual digital data to advocate for the advantages of your offerings. Our technology-driven service facilitates real-world research that integrates unique, day-to-day behavioral information, thereby benefiting clinical, medical affairs, and commercial divisions, all while utilizing Evidation's virtual research site, Achievement. With adaptable study designs, strategies for device integration, and streamlined protocol management, we ensure efficient study operations. Additionally, we offer the flexibility for sponsorship either by us or your organization, allowing for tailored collaboration.

Aiforia provides pathologists and researchers in both preclinical and clinical laboratory settings with advanced deep learning and cloud-based technologies designed to enhance their image analysis processes and operational efficiency. By facilitating the discovery of new disease biomarkers for researchers, assisting R&D scientists in accelerating the development timeline of innovative drugs, and aiding pathologists in improving the precision of cancer diagnoses, Aiforia leverages its extensive expertise to revolutionize healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost their efficiency and enhance diagnostic accuracy, Aiforia Clinical Suites deliver a comprehensive array of AI-assisted diagnostic tools, smart visualization features, quality control measures, and automated pre- and post-screening capabilities. We are in the process of creating Suites tailored for some of the most common cancers worldwide and have achieved CE-IVD certification for our AI models focusing on lung and breast cancer. Continuous advancements in our technology promise to further improve patient outcomes and streamline lab workflows.

Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.

Over 70% of healthcare information is contained within clinical documents, including reports, patient charts, clinician notes, and discharge summaries, allowing our specialized Natural Language Processing and AI Engine to extract essential concepts, attributes, and contextual information that drive business insights, enhance billing processes, assess and categorize patient risks, calculate quality metrics, and gather patient sentiment and outcome data. By tapping into difficult-to-access or previously unused data sources, you can significantly improve your clinical research or business intelligence efforts. Our extensive database features thousands of clinical concepts, including genomic biomarkers, symptoms, side effects, and medications, enabling the identification of disease characteristics and risk factors from clinical documents to better stratify patients and elevate the standard of care. Moreover, we ensure the protection of data subjects' identities while preserving the usefulness of the data through effective document de-identification strategies. This approach not only safeguards privacy but also empowers healthcare organizations to make informed decisions based on the most comprehensive data available.

Enhance your revenue from clinical research by identifying shortcomings in patient care. CliniWorks’ AccelInsight™ Analytics Application facilitates Population Health Management by empowering clinical decision-making with insightful reports and tools designed to pinpoint deficiencies in patient treatment across various disease categories. This application delivers tailored, near-real-time analytics derived from comprehensive structured and unstructured data sources, including patient medical records, to uncover opportunities for quality enhancement, population risk stratification, and gap analysis in care management. Additionally, AccelCare™ equips healthcare providers to efficiently implement preferred intervention strategies based on established best-practice protocols, align patient cases from medical records with preferred medical rules and workflows, and activate corrective workflows along with real-time notifications to quality assurance teams, management, and healthcare providers, thereby streamlining the entire process of patient care. This holistic approach not only drives clinical excellence but also fosters a culture of continuous improvement within healthcare organizations.

Flatiron Health's Evidence Solutions provide a versatile method for generating real-world evidence, both prospective and retrospective, which aids life sciences companies in efficiently meeting their oncology research objectives. At the heart of these offerings is Flatiron Horizon, a comprehensive platform that combines a rich database of more than 5 million anonymized patient records and 1.5 billion data points, coupled with advanced curation techniques and disease-specific machine learning models. This innovative platform is designed to facilitate various phases of the biopharma lifecycle, including discovery, clinical study design, regulatory submissions, and post-marketing commitments. Furthermore, Flatiron's services deliver customized real-world data configurations that cater specifically to oncology, enabling prospective evidence generation through minimally invasive studies and optimizing protocols for better patient identification. Additionally, the platform ensures a streamlined transfer of data from electronic health records to electronic data capture systems with the functionality of Flatiron Clinical Pipe, enhancing overall research efficiency and effectiveness. Such capabilities position Flatiron Health as a leader in transforming oncology research through the power of real-world data.

Enhance your ability to manage risks and deliver superior care to your community through the disease prediction models offered in CARE™. We provide a comprehensive perspective of medical claims data at a national scale, which can be tailored to meet the specific needs of our clients at a granular level. Our sophisticated models sift through billions of medical claims to pinpoint risk indicators for early disease development or the necessity for surgical interventions. Armed with this vital information, healthcare providers can initiate diagnoses and treatments earlier, which has the potential to save lives. While our prediction models are trained on extensive national data, they can also be applied to your own EHR, population health platform, or member claims database for a more personalized approach. Additionally, our physician matching feature aids in aligning patients with the most suitable providers, thereby enhancing their care journey towards optimal treatment outcomes. By utilizing clinically significant data, our advanced disease prediction models identify individuals who are at risk of developing a condition, empowering you to proactively engage with them and commence treatment before the situation escalates. This proactive engagement not only improves patient outcomes but also enhances the overall efficiency of healthcare delivery.

Enhancing the care quality and outcomes for individuals battling cancer necessitates a cooperative effort among healthcare providers, researchers, cancer institutions, and the patients themselves. Oncora's user-friendly software platform empowers all parties involved to gather and utilize real-world data, thereby facilitating informed healthcare decisions that prioritize patient welfare. Our solutions are specifically designed for healthcare professionals who are committed to advancing cancer treatment results. By simplifying workflows, alleviating documentation challenges, and optimizing care through smart software solutions, we enable a more efficient healthcare experience. Our intuitive tools allow for the capture and visualization of regulatory-grade real-world data, essential for informed decision-making. With sophisticated reporting capabilities, you can measure quality and enhance operations to elevate patient care. Engaging in rigorous clinical research alongside leading cancer care experts further reinforces our commitment. The intuitive, web-based software we offer is tailored to meet the needs of your cancer center, providing data and tools that expedite clinical breakthroughs and innovations. Ultimately, our mission is to transform cancer care through technology and collaboration, ensuring that patients receive the highest standard of care available.

Koneksa stands out as a prominent digital biomarker firm catering to the pharmaceutical and biotechnology sectors, focusing on the creation, testing, and validation of digital biomarkers that assist clients in assessing how treatments affect patients. Established in 2013, Koneksa delivers comprehensive remote clinical trial support by integrating digital health technologies, therapeutic knowledge, and swift, user-friendly remote data gathering to enhance understanding of patient health outcomes. Their innovative and validated data algorithms are designed for immediate use in treatment development initiatives, facilitating the detection of signals more rapidly than conventional methods. The company's cloud-based Software as a Service (SaaS) platform enables real-time integration of multiple endpoints, providing instant access to data and supporting informed, cost-effective decision-making early in the trial process. Additionally, this platform’s capability to gather extensive remote data at higher frequencies presents opportunities for obtaining ecologically valid measures, which can lead to a reduction in sample size while maintaining the integrity of the research. By continuously evolving their tools and methodologies, Koneksa aims to redefine how clinical trials are conducted in the modern age.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

DoseMeRx stands as the first and largest Bayesian dosing platform worldwide, tailored specifically for clinical use. Accelerate your journey toward clinical objectives with our proven platform, which notably enhances patient outcomes while reducing expenses. Uniquely, we are the sole Bayesian dosing solution globally that holds HITRUST certification, providing you with peace of mind regarding the utmost protection and integrity of patient data. Experience seamless continuity of care throughout your healthcare system with just a few simple steps. Easily standardize workflows and fine-tune your therapeutic drug monitoring initiatives. Our diverse array of drug models spans multiple therapeutic fields, such as vancomycin and infectious diseases, transplant medicine, cardiovascular and coagulation management, as well as oncology and pediatrics, ensuring comprehensive support for a wide range of clinical scenarios. This versatility empowers healthcare providers to deliver tailored treatment solutions effectively.

Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.

At Genospace, we recognize that the evolution of precision medicine is being propelled by advancements in genomics, yet the challenge of effectively scaling its implementation remains unresolved. Our mission is to bridge this gap. Our innovative platform aims to transform biomedical data into valuable insights that are easily accessible for all, particularly for those actively involved in delivering care. Equip your clinicians and researchers with essential information that empowers them to make well-informed choices while participating in our goal of utilizing intricate molecular data to enhance patient outcomes and speed up the processes of drug development and research. In this context, the significance of large-scale population data for drug discovery and research cannot be overstated. Utilize cohort-driven analyses through the Genospace platform to support your research initiatives. We have a strong focus on clinical trial research, enabling the Genospace platform to seamlessly align fragmented patient information with intricate trial requirements, thus facilitating quicker patient recruitment. Furthermore, our platform is designed to integrate genomic medicine into standard clinical care practices, making it easier than ever to harness the power of genomics in everyday healthcare. Together, we can push the boundaries of what’s possible in patient care and research.

The Innovaccer Health Cloud will accelerate your transformation. You can unify patient data, create comprehensive financial and clinical insights, and innovate faster. We help providers integrate disparate patient information to provide actionable insights at point of care, collaborate across care teams and achieve better outcomes. We facilitate connectivity and collaboration among payers, providers, members, and members to manage risk and compliance as well as rising member expectations. We assist medtech and biopharma companies to build digital solutions at the intersection of healthcare and better use real-world data throughout the value chain. Transform from silos to an open platform that unifies healthcare data into one longitudinal patient record that allows for whole-person care.

HolCare EHR+ is an advanced cloud-based electronic health record system tailored to address the requirements of mental health organizations, telepsychiatry practices, research institutions, and innovative care models. The use of Measurement-Based Care (MBC) has demonstrated significant improvements in patient care, enhanced treatment responses, and better decision-making for clinicians, ultimately leading to improved health outcomes. Nonetheless, the lack of direct integration with an EHR can make MBC implementation difficult and may hinder overall productivity. HolCare EHR+ effectively addresses this issue by incorporating fully integrated MBC, enabling seamless collection of essential measures that enhance patient care. Furthermore, its HL7 FHIR native support facilitates the incorporation of various third-party health technologies. This standardization avoids the pitfalls of costly and time-consuming custom integrations, allowing for a more efficient platform that can exchange both clinical and non-clinical data with collaborative partners, thereby streamlining workflows across the health care ecosystem. Ultimately, HolCare EHR+ empowers organizations to adopt a more holistic approach to patient management and care delivery.

A cloud platform that is accessible from anywhere, infinitely scalable, and powered by AI offers collaborative features while adhering to the strictest security and compliance standards. This user-friendly software, designed by specialists in neuroimaging and data science, addresses the specific and complex requirements of the neuroscience field. Customized to suit your particular needs, it supports a wide range of activities, including research, clinical trials, point-of-care applications, algorithm development, and the utilization of brain-related data. The platform facilitates global data aggregation and consolidates imaging studies into a single cloud environment. It provides an efficient, comprehensive management solution for clinical, real-world data, and medical imaging information. Users receive tailored, expert assistance throughout their studies to ensure successful outcomes. Additionally, it features centralized reading capabilities and the option to compare quantitative results against a normative database. The platform also guarantees high-quality, shareable reporting and data export options to streamline the submission approval process, making it an invaluable tool for neuroscience professionals. Furthermore, its innovative design enhances collaboration among researchers and clinicians, fostering a community dedicated to advancing the field.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

To enhance technological productivity, data analysis, and medical requirements, Aurora is presently utilized by top hospitals across the US and Europe for overseeing every facet of patient IVF cycles and conducting research on patients with Cardiomyopathy. The landscape of medicine, including the diseases we encounter and the decisions we face, is set to evolve significantly. Our software is designed with adaptability in mind, enabling swift and simple modifications tailored to the specific demands and procedural standards of your organization. To make informed treatment choices, a comprehensive view of patient data is essential, encompassing phenotype and genotype information, laboratory outcomes, family histories, genealogies, and textual reports. All clinical information is systematically gathered, evaluated, and delivered in a unified platform. Clinicians can explore and access this data in various formats, including complete longitudinal studies. The development of these products involves collaboration between software and data engineers and clinicians from each specialty, ensuring that the tools meet real-world needs effectively. By integrating cutting-edge technology with clinical expertise, Aurora aims to significantly improve patient outcomes and streamline healthcare processes.

Our extensive and adaptable range of solutions and services is built upon a strategic framework aimed at empowering organizations to understand and forecast trends within populations, actively involve individuals, their families, and care teams in proactive measures, and effectively oversee health outcomes for improved well-being. Unlike traditional medicine, which typically concentrates on the individual and equates "health" with the absence of disease, population health management broadens the scope by enhancing initiatives across whole groups and prioritizing the management and prevention of chronic conditions. To successfully oversee the outcomes of population health, it is crucial to address the underlying causes of health issues, allowing for the anticipation, prevention, and management of such challenges before they arise. By integrating clinical data with social determinants of health (SDoH), healthcare providers can gain valuable insights that not only improve individual care but also foster collaborations with communities to promote overall health and wellness. Ultimately, this holistic approach aims to create healthier populations and more effective healthcare systems.

DigiLife is a leader in HIPAA compliant connected healthcare and tele-health solutions. It empowers remote patient monitoring and assisted treatment. Prodoc (a.k.a. DigiCare Live is built on top our proprietary technology platform. It supports basic EHR, practice administration, chronic condition monitoring (via health devices), remote diagnosis via telemedicine and care coordination (via assisted caregivers). It can be used by specialists, physicians, and care institutes that involve one or more clinics. It integrates with many of the most popular EMRs by using FHIR standards for clinical information exchange. It enhances health management by sending custom reminders and smart alerts to patients for lab tests, medicine, or telemedicine visits. It supports the most popular health and fitness devices such as Fitbit and Google Fit, Withing and iHealth. ** You can tailor your order by using custom development options

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

Jvion transcends conventional predictive analytics by uncovering concealed patient risks associated with various diseases and clinical scenarios while also assessing whether those risk patterns can be redirected toward more favorable outcomes. Utilizing our prescriptive AI, we offer tailored recommendations for individual patients by considering a range of factors, including clinical, socioeconomic, and behavioral data, along with established best practices. With this insightful information, healthcare organizations are empowered to enhance quality, reduce costs, and elevate the overall patient experience. We analyze a wide array of clinical, socioeconomic, environmental, and behavioral data to uncover hidden health and financial vulnerabilities. By evaluating modifiable patient characteristics, we can formulate targeted action plans for each individual. Our approach delivers evidence-backed, prioritized, and patient-specific recommendations that seamlessly align with existing workflows. In light of the ongoing pandemic, the concept of home care has gained renewed significance, as many patients now prefer to seek treatment at home to minimize the risk of exposure to Covid-19 and other illnesses. This shift underscores the necessity for innovative healthcare solutions that cater to the evolving needs of patients in a post-pandemic world.

Our comprehensive primary source dataset stands out as the most extensive and varied resource available for researchers and analysts in the healthcare sector, enabling them to gain profound insights aimed at enhancing both health outcomes and economic efficiency. Propel the future of healthcare by utilizing pertinent data extracts that encompass a wide spectrum of care, featuring detailed provider identification, a comprehensive view of the patient journey, and the capability to securely connect with external data sources. Boost research efforts and elevate healthcare outcomes with longitudinally linkable, deidentified real-world data that is crucial for informed decision-making. We conduct over 1,100 rigorous data integrity checks to guarantee both consistency and precision, employing industry-standard methodologies for quality assurance and seamless integration. Uncover innovative insights through rich and pertinent real-world data. Additionally, harness custom extracts from both open and proprietary primary sources to expedite research processes and enhance clinical outcomes alongside provider performance. Our commitment to data quality and relevance ensures that healthcare professionals can make the best decisions possible.

As organizations broaden their onsite clinic services to encompass primary care, urgent care, chronic disease management, and health and wellness offerings, a standard occupational health IT system is insufficient to support this expanded scope. Enterprise Health integrates occupational health and compliance, clinical care, and employee engagement into a single ONC-ACB certified EHR, providing a comprehensive solution that effectively addresses both occupational health and safety as well as corporate wellness initiatives. This platform not only facilitates the tracking and management of health surveillance activities, work-related illnesses and injuries, and clinical services but also encourages employees to take a proactive role in their health, wellness, and compliance. With Enterprise Health’s versatile toolsets, employees can easily communicate with clinical staff and gain electronic access to vital information, enabling them to enhance their own health and that of their families. Furthermore, this integration fosters a culture of wellness within the organization, ultimately leading to improved employee satisfaction and productivity.

At Clinipace, we provide an unparalleled level of collaboration and control that far exceeds what is typically available in conventional CRO settings. Our mission is to effectively guide you through the complexities of your clinical development program. As a global, full-service contract research organization, we prioritize a personalized approach to clinical research. We emphasize flexibility and collaboration, complemented by our regulatory expertise and leadership in various therapeutic areas. Our goal is to transform the landscape of clinical research across numerous fields, including oncology, rare diseases, gastroenterology, nephrology, and women's health. By integrating cutting-edge technology and an adaptive mindset, Clinipace is dedicated to shaping the future of drug development and enhancing healthcare outcomes. Our commitment to innovative solutions ensures that we remain at the forefront of industry advancements.

Enhance the health and care of your patients with EpicCare, which offers customizable screens, workflows, and specialty applications that are both quick and adaptable. With the aid of predictive analytics and integrated decision support tools, clinical practices can achieve improved outcomes. Routine tasks are optimized for efficiency, allowing for faster completion. Mobile applications ensure that you remain connected no matter your location. Additionally, you can expedite the recruitment of study participants, carry out independent research, and integrate your discoveries into clinical practices. Healthcare providers have recognized it as the top acute and ambulatory EMR for enhancing physician productivity and efficiency. The system is equipped with flexible, pre-built content tailored for various specialties, enabling you to concentrate on patient care. Furthermore, specialty steering boards, composed of field experts, actively contribute relevant content and guide development to address the genuine needs of various specialties, ensuring that the system remains aligned with real-world clinical demands. This commitment to continuous improvement makes EpicCare an invaluable asset for healthcare professionals.

ConcertAI stands out as a prominent provider of AI-driven solutions within the healthcare sector, particularly in the field of oncology. Their core mission revolves around enhancing patient outcomes and expediting insights by leveraging top-tier real-world data, cutting-edge AI technologies, and deep scientific knowledge. The company presents an array of products and services aimed at improving both clinical research and patient care experiences. Their Real-World Data Products deliver extensive, customized datasets that cater to diverse research needs across various enterprises. By simplifying clinical trial processes, their digital trial solution ensures efficiency, while the Clinical Trial Optimization (CTO) platform employs extensive AI capabilities to refine the design and implementation of trials specifically in oncology and hematology. Additionally, in partnership with NeoGenomics, ConcertAI has introduced CTO-H, a software-as-a-service (SaaS) solution that concentrates on hematological malignancies, providing sophisticated research analytics and optimizing operational workflows. This integration of advanced technologies not only enhances research capabilities but also significantly contributes to the advancement of patient care in complex medical fields.

Tempus AI, a prominent health technology firm based in Chicago, Illinois, is dedicated to transforming patient care through advanced artificial intelligence and precision medicine. By utilizing data and AI, the company strives to create personalized treatment plans across a range of medical specialties, such as oncology, cardiology, radiology, and mental health. Their all-encompassing platform combines genomic sequencing, clinical data, and AI-powered analytics, equipping healthcare providers and researchers with actionable insights. Tempus offers a holistic understanding of patients via various testing methods, including tissue and liquid biopsies, DNA and RNA sequencing, somatic and germline tests, as well as tumor-normal matched profiling and minimal residual disease monitoring options. Additionally, they provide a swift and dependable platform for ordering tests, gaining patient insights, and seamlessly integrating AI-driven technologies into practice. Furthermore, Tempus features an innovative generative AI-enabled clinical assistant that places patient insights readily at your fingertips, enhancing the overall efficiency of healthcare delivery. This commitment to leveraging cutting-edge technology exemplifies Tempus AI's mission to improve health outcomes and advance medical research.

The expenses, intricacies, and lengthy timelines tied to traditional methods of evidence generation hinder the agile nature of research and the broader incorporation of genuine patient insights within treatment development and commercial processes. Our HyperStream serves as the largest real-time stream of patient experience data globally, documenting the genuine digital narratives of diseases as expressed by real patients on various online platforms. Pharos acts as a web-based tool for evidence generation and a research framework that leverages its combined data streaming and AI functionalities to effectively gather online patient experience data, allowing teams to swiftly uncover vital evidence when necessary. Thus far, the Pharos Suite has proven effective in generating valuable evidence and patient insights across a variety of therapeutic areas and medical conditions, demonstrating its versatility and impact on research practices. This innovative approach not only enhances the speed of evidence gathering but also enriches the understanding of patient experiences in real-time.

Comprehensive recommendations are provided throughout the entire patient journey, ensuring every phase of care is addressed effectively. There is a strong call-to-action that facilitates the monitoring and evaluation of both commercial and clinical outcomes. Disease-specific risk algorithms have been established for conditions such as diabetes, cardiovascular issues, kidney health, and liver health, among other therapeutic areas. A Complete Wellness Score is utilized to evaluate the likelihood of requiring inpatient care. Additionally, proprietary data and established protocols are complemented by user-friendly clinical content tailored for patients. This content is not only ready for immediate use but can also be customized for various purposes and formats. Intelligent decision support is available, leveraging both established protocols and machine learning to analyze prescribers' patterns in medication prescriptions. Furthermore, the most advanced customer feedback system has been custom-designed specifically for healthcare organizations. The system operates on a multi-parameter engine that considers factors such as expenditure, compliance in a timely manner, preventive health checkups, improvements in clinical parameters and outcomes, as well as demographic information, providing a holistic view of patient care and intervention needs. Overall, this approach aims to enhance patient outcomes while streamlining the healthcare process.

Genoox is revolutionizing the field of genomics through its dynamic and expanding community, which enables the accumulation of the most pertinent database and facilitates the delivery of actionable, real-world genomic insights that significantly affect lives, enhance clinical outcomes, and influence healthcare business practices. By harnessing community power, Genoox merges public data with community-generated information to optimize the journey from DNA sample to clinical report, thereby improving patient care through the accessibility and applicability of genomic data at critical moments. The company's innovative solutions are transforming the landscape of genomics, while also supporting research and life sciences enterprises with an insightful platform that leverages real-world data and evidence, bolstered by comprehensive genomic analytics, which assists researchers in simplifying intricate genomic information and achieving meaningful breakthroughs with cutting-edge genetic tools. Moreover, Genoox collaborates with biosystems firms like DNA sequencing companies to integrate its advanced genomic engine with specialized assays, further enhancing the capabilities of the entire genomics ecosystem. Ultimately, Genoox stands at the forefront of genomic innovation, consistently aiming to empower healthcare professionals and researchers alike.

The biopharmaceutical sector today is characterized by its intricate nature, driven by increasing demands for enhanced specificity and safety, the emergence of new treatment modalities, and a deeper understanding of complex disease mechanisms. To navigate this intricate landscape, a thorough grasp of therapeutic behavior is essential. Modeling and simulation techniques serve as a powerful method to investigate biological and physicochemical phenomena at the atomic scale, which can inform experimental work and expedite both discovery and development timelines. BIOVIA Discovery Studio consolidates over three decades of rigorously validated research alongside cutting-edge in silico methodologies, including molecular mechanics, free energy assessments, and the development of biotherapeutics, all within a unified platform. This comprehensive toolkit empowers researchers to delve into the subtleties of protein chemistry, facilitating the discovery and optimization of both small and large molecule therapeutics from the identification of targets through to lead optimization, thereby enhancing the overall efficiency of the drug development process. In an era where precision medicine is increasingly pivotal, such tools are indispensable for advancing therapeutic innovation.

Behavioral health constitutes a crucial yet frequently neglected component of overall wellness. The impact of mental and substance use disorders affects an astonishing 970 million individuals globally, contributing to an economic burden exceeding US $1 trillion each year. In spite of this escalating crisis, advancements in treatment and understanding have not kept pace with other medical fields. Alarmingly, less than half of those suffering from major depression, which is the most prevalent mental health disorder, achieve remission with existing therapies. Increased awareness has sparked a greater demand for services in a system that remains ill-equipped to address the extensive complexities of this need. There exists a significant evidence gap that hinders progress in research and innovation, largely due to the inherent challenges within behavioral health, such as intricate disease causes, a shortage of measurable biomarkers, and fragmented institutional approaches. Even after many years of dedicated research, we remain largely in the dark about how to effectively treat most behavioral health conditions, indicating a critical need for renewed focus and resources in this field. Ultimately, bridging this gap is essential for improving the lives of millions affected by these disorders.

SaleSpider Media Inc stands out as a premier Digital Media Company dedicated to enhancing customer acquisition and elevating brand visibility for both Fortune 1000 companies and small to medium-sized businesses. Each month, we effectively engage over 212 million potential buyers and business leaders. Our consistent track record demonstrates our excellence across various sectors, including HealthCare, Telecom, Automotive, Education, Insurance, Retail, Travel, Agriculture, Consumer Electronics, Gambling, Financial Services, and B2B markets ranging from small enterprises to large-scale IT firms. Advertisers reap the rewards of our extensive global outreach, direct inventory access, first-party data, and competitive pricing strategies. We prioritize metrics and focus on delivering tangible, measurable outcomes. Our targeted campaigns, especially directed at Healthcare Professionals by specialty, utilize NPI list matching and display advertisements. Whether working in their offices, clinics, or hospitals, or while conducting research on products, services, symptoms, medications, treatments, or clinical trials, our audience remains connected and engaged. Additionally, our innovative strategies ensure that we adapt to the evolving needs of our clients and their markets.

Dexur compiles claims data from diverse sources and, by leveraging advanced algorithms, offers a range of insights to organizations within the Life Sciences sector, such as those involved in Sales and Marketing, Disease Burden Data, HEOR & RWE, and Patient Journey analysis. By utilizing its anonymized claims database, Dexur creates comprehensive dashboards and disease burden data at multiple levels, including national, regional, and hospital scales. Insights pertaining to specific diseases, such as Diabetes and Chronic Kidney Disease, encompass metrics like total cost of care, readmission rates, mortality figures, nursing home expenses, length of hospital stays, and other disease-specific indicators. The Life Sciences App Suite from Dexur provides valuable insights into various financial and clinical quality metrics, facilitating in-depth analysis of Hospitals, Ambulatory Surgery Centers (ASCs), Providers, and Integrated Delivery Networks (IDNs). This strategic approach enables life sciences companies to effectively tailor their products and services to the most appropriate clientele, ultimately enhancing their market reach and impact. By streamlining their targeting efforts, these organizations can optimize resource allocation and improve patient outcomes.

Engage with a medical-focused generative AI that not only elucidates its responses but also cites relevant references, refreshes its medical knowledge on a daily basis, and allows users to personalize and select knowledge bases. This AI comes equipped with a pre-loaded database and has been trained using over 2,300 reference datasets put together by experts in the medical field, encompassing a wide array of terminologies, medical research, clinical trials, patents, population health insights, costs, as well as public and regulatory information. It indexes numerous sources of medical research and data, ensuring a comprehensive understanding of the available information. The system is designed to receive daily updates on the latest medical findings, clinical trial results, and evolving terminologies, making it capable of processing vast quantities of documents, potentially reaching into the millions or billions. Moreover, the cluster can be scaled according to specific requirements. As a type of conversational AI, a medical chatbot employs natural language processing (NLP) technologies to communicate with users, delivering valuable medical information, guidance, or assistance. These chatbots serve various functions, including addressing general inquiries regarding diseases, health concerns, and available treatment options, thus enhancing the accessibility of medical knowledge for users everywhere.

Historically, clinical trials and medical research operated separately from the routine care provided in local healthcare facilities and by individual doctors. Many physicians remained unaware of ongoing research initiatives, leaving patients largely uninformed about studies that could enhance their treatment outcomes or health. Elligo has transformed this landscape by facilitating unprecedented participation in clinical research through access to a vast network of over 150 million patients and their comprehensive data, enabling doctors to present research opportunities to patients who might not otherwise encounter them. Traditional methods of recruiting participants often face challenges, such as the need for patients to travel to specific research sites, which can limit involvement. Moreover, studies indicate that patients are more inclined to participate in research when it is associated with their trusted healthcare provider, underscoring the importance of integrating clinical research into familiar medical environments. This approach not only bridges the gap between research and patient care but also empowers individuals to take part in potentially life-changing medical advancements.

Retrieving a patient's medical records is now just a search away, thanks to the PRISMA health information search engine, which consolidates data from primary care providers, specialists, clinics, urgent care centers, and hospitals into a comprehensive, searchable timeline of a patient’s health. Our Customer Success Stories showcase how our healthcare IT is being utilized in real-world scenarios, highlighting how eClinicalWorks customers are enhancing value-based care and overall healthcare outcomes. With a dedicated team of 5,000 employees, eClinicalWorks is committed to advancing healthcare in collaboration with our clients. Over 130,000 physicians across the United States, along with more than 850,000 medical professionals worldwide, depend on our EHR software for thorough clinical documentation as well as solutions that encompass telehealth, population health, patient engagement, and revenue cycle management. As a privately held company focused on innovation and excellence, our primary goal is to equip our customers with secure, cloud-based solutions that meet their evolving needs. Our commitment to improving healthcare continues to drive every aspect of our operations.

Harnessing the world's largest real-time data stream on patient experiences, coupled with advanced Artificial Intelligence for analysis and a robust analytics platform that distills patient feedback into clear insights, empowers stakeholders to uncover unmet needs and gain comprehensive insights into the challenges of disease and treatment, ultimately facilitating the design and implementation of more tailored therapies while consistently prioritizing patient care. It can be disheartening to realize that, given existing resource limitations and methodological constraints, achieving optimal patient outcomes can often feel unattainable. By selecting specific diseases, age groups, geographical locations, and any necessary inclusion or exclusion criteria for your research, you can streamline the process of gathering real-world data on a global scale, thereby accessing a vast array of patient populations much more efficiently and without unnecessary complications. This approach not only accelerates research but also enhances the overall understanding of patient experiences in diverse contexts.

Accessible for practitioners of every experience level, our innovative approach allows for straightforward wound assessment by simply snapping a photo with a smartphone, enabling clinicians to analyze wound conditions and generate essential documentation for reimbursement purposes. By effectively managing wound care, healthcare providers can enhance their star ratings and reduce the likelihood of patient readmissions, ultimately transforming wound care achievements into powerful marketing assets that draw in more patients. This advancement empowers professionals to accept more intricate wound cases with assurance. At Swift, we are convinced that the evolution of healthcare will be propelled by revolutionary technologies that are thoughtfully created, promoting unprecedented standards of clinical care. While smartphone cameras have maximized their potential in clinical scenarios, the healthcare sector is poised for significant progress through the introduction of new technologies—both in hospitals and at home—that allow us to rethink care delivery. Thus, Swift has developed the most sophisticated smartphone imaging platform in the world, capable of capturing research-quality clinical images anywhere patients might be, ensuring that quality care is always accessible. This innovation not only streamlines the process but also enhances patient outcomes across the board.

We are at the forefront of precision medicine, alleviating the strain on healthcare systems through our innovative automated analysis, diagnosis, and treatment solutions that cater to healthcare providers and patients globally. Congenica emerged from groundbreaking research conducted at the Wellcome Sanger Institute and the UK's National Health Service. Our offerings integrate cutting-edge technology, top-tier automation, and artificial intelligence, allowing our distinct platform to be utilized across various human diseases where genomic information plays a crucial role in revealing actionable insights. As a digital health company, we specialize in software and solutions designed for the large-scale analysis and interpretation of genomic data. Our fully automated system, enhanced with robust APIs and machine learning capabilities, aims to lighten the load on specialist staff, improve case processing efficiency, speed up decision-making, and simplify reporting. Our platform is certified, accurate, and secure, empowering clinical decisions with the utmost confidence in the resulting clinical outcomes, and we continuously strive to innovate and expand our capabilities to meet the evolving needs of the healthcare landscape.

PEPID has been providing web-based point of care solutions for healthcare professionals for more than 20 years. These solutions allow them to accurately dose patients and diagnose medical conditions, as well as detect drug interactions and allergic reactions. PEPID products are integrated into the systems of hospitals, universities, schools, and clinics around the globe. PEPID simplifies medical information with a built-in workflow that was developed over years of interaction with pharmacists, doctors, and nurses. This unmatched organization allows healthcare professionals to have faster access and better clinical performance. It also gives them greater mobility. PEPID is used by schools to improve learning in the classroom, clinical, or study setting. PEPID is a better risk management system, greater productivity, and higher staff and patient satisfaction.

Altris AI is an innovative clinical decision support system powered by artificial intelligence and hosted in the cloud, aimed at helping eye care professionals with the interpretation of OCT scans and clinical decision-making. This platform streamlines the identification of pathological OCT scans while being capable of recognizing over 70 different retina pathologies and biomarkers, some of which are uncommon. Among its features are the ability to assess severity, analyze retina layer thickness, segment layers, detect pathologies, and perform both automatic and manual measurements. Altris AI seamlessly works with all OCT devices and accommodates various formats such as DICOM, JPEG, and PNG. The system holds FDA clearance, CE certification, and adheres to GDPR and HIPAA regulations, ensuring robust data security and patient confidentiality. By incorporating Altris AI into their workflow, eye care practitioners can enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases, ultimately leading to better patient outcomes. Additionally, this advanced technology empowers eye care professionals to make more informed decisions, fostering an environment of improved patient care and treatment strategies.

AviTracks-DM serves as a web-based clinical decision support tool designed to assist in the management of patients dealing with multiple chronic conditions. This system features an automated workflow along with real-time interfaces for electronic medical records (EMR) and laboratory data, making it a valuable asset for hospitals, health systems, and large specialty clinics that care for high-acuity patients, where immediate information is crucial for optimizing patient outcomes. By utilizing AviTracks-DM, healthcare providers can enhance the quality of care for those at high risk, streamline information sharing, and accommodate a greater number of patients without the necessity of expanding staff. The system automatically refreshes the status of each patient, providing updates on pending lab results, lab work that requires review, critical alerts, and reminders for follow-up care. Furthermore, it includes customizable reporting features that help generate necessary documentation for adherence to quality improvement initiatives and performance-based compensation measures. Overall, AviTracks-DM not only simplifies patient management but also supports healthcare facilities in achieving their clinical and operational goals.

Lifepoint Informatics stands as a reputable frontrunner in the realm of healthcare information technology, driving the shift towards value-based healthcare through straightforward clinical integration, health information exchange, and robust data interoperability solutions tailored for hospitals, health systems, clinical laboratories, diagnostic imaging centers, health insurers, and accountable care organizations. Our offerings are built upon a cohesive workflow platform, ensuring seamless interoperation across various modalities, application layers, and end-user devices. Customers of Lifepoint appreciate the intuitive and transparent nature of our data integration solutions, which effectively promote health information exchange, support successful outreach connectivity, and facilitate EMR integration, EHR interfacing, physician portals, population health management, and quality reporting among diverse clinical systems. Furthermore, our commitment to innovation continuously enhances the healthcare landscape, allowing providers to deliver improved patient outcomes and experiences.

CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.